Inozyme Pharmaincis A Clinical Stage Biopharmaceutical Company Dedicated To Developing Innovative Therapies For Rare Diseases That Impact Bone Healthblood Vessel Functionand Soft Tissue Mineralizationthe Company Focuses On The Ppi Adenosine Pathwaywhich Plays A Vital Role In Maintaining Skeletal And Vascular Healthinozyme Aims To Address Conditions With High Unmet Medical Needstranslating Scientific Insights Into Effective Treatments The Company S Lead Productinz 701Is An Investigational Enzyme Replacement Therapy Designed To Restore Pyrophosphate And Adenosine Levelsthis Therapy Targets Diseases Such As Enpp1 Deficiencyabcc6 Deficiencyand Calciphylaxiswhich Are Associated With Severe Mineralization Disordersinozyme Collaborates With Cliniciansresearchersand Patient Advocacy Groups To Enhance Treatment Access And Support Clinical Trial Participationemphasizing A Patient Centric Approach In Its Development Process
No conferences found for this company.
| Company Name | Inozyme Pharma |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
